Sensei Biotherapeutics to Participate in Jefferies Healthcare Conference
25 mai 2022 07h30 HE
|
Sensei Biotherapeutics
BOSTON, May 25, 2022 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer,...
Sensei Biotherapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
10 mai 2022 07h30 HE
|
Sensei Biotherapeutics
- SNS-101 preclinical data provide encouraging validation of pH-sensitive approach to inhibiting VISTA with high selectivity to treat solid tumors - - Cash runway extended into the first quarter of...
Global Immuno-Oncology Diagnostics Market Research Report 2022: Explosion in Immuno-Oncology Therapies Creates an Exploding Diagnostic Market - Forecast to 2027
29 mars 2022 04h13 HE
|
Research and Markets
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates" report has been added to ResearchAndMarkets.com's offering....
$3.27 Billion Worldwide Oncology Biosimilars Industry to 2031 - Identify Growth Segments for Investment
22 mars 2022 05h33 HE
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Global Market Report 2022: By Drug, By Cancer, By Distribution" report has been added to ResearchAndMarkets.com's offering. This...
Autolus Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on March 10
21 févr. 2022 07h00 HE
|
Autolus Therapeutics plc
LONDON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...
Global $49.77 Cancer Monoclonal Antibodies Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F
10 janv. 2022 05h18 HE
|
Research and Markets
Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering....
Worldwide Immuno Oncology Assays Industry to 2026 - Clinical Trials to Cure Different Cancers in Immunotherapy Presents Opportunities
05 janv. 2022 06h38 HE
|
Research and Markets
Dublin, Jan. 05, 2022 (GLOBE NEWSWIRE) -- The "Immuno Oncology Assays Market Research Report by Indication, Product, Technology, Application, and Region - Global Forecast to 2026 - Cumulative Impact...
Worldwide T-Cell Therapy Industry to 2026 - Expanding Gene Therapy Marketspace Presents Opportunities
01 déc. 2021 09h38 HE
|
Research and Markets
Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "T-Cell Therapy Market Research Report by Modality, by Therapy Type, by Indication, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19"...
Global Market for Immuno-Oncology Diagnostics 2021: Diagnostics Play New Key Role in Therapeutic Development and Clinical Trials
01 nov. 2021 05h48 HE
|
Research and Markets
Dublin, Nov. 01, 2021 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates, 2022 - 2026" report has been added to ResearchAndMarkets.com's...
Global $92.97 Bn Immuno-Oncology Drugs Markets, 2015-2020, 2020-2025F, 2030F: Focus on Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines
29 sept. 2021 06h18 HE
|
Research and Markets
Dublin, Sept. 29, 2021 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Drugs Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...